approval letter

An official communication from the FDA to inform a New Drug Application/Biologic License Application (NDA/BLA) applicant of its decision to allow commercial marketing of a drug product.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.